Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ishige sinicola extract may help prevent muscle atrophy through its antioxidant and anti-inflammatory effects.

JAK inhibitors offer new hope for treating severe alopecia areata.

QLT0267 stops hair follicle cell growth and movement.

Topical IKKα inhibitors may help prevent CCS tumours.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Gene sequencing is crucial for diagnosing Junctional epidermolysis bullosa.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Baricitinib is an effective treatment for severe alopecia areata.

A new gene mutation linked to KID syndrome was found, expanding genetic knowledge.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Early diagnosis and treatment of iodine deficiency in buffalo calves is crucial for their healthy growth.

Tay syndrome is a unique genetic disorder causing skin, hair, and developmental issues.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

Macrophages play a crucial role in skin wound healing, with their numbers and sizes changing over time.

Ixekizumab has known and some unexpected side effects.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.